Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-133,830
Closed -$7.57M 806
2014
Q3
$7.57M Sell
133,830
-125,760
-48% -$7.06M 0.02% 434
2014
Q2
$14.3M Sell
259,590
-279,606
-52% -$15.3M 0.04% 337
2014
Q1
$29.2M Sell
539,196
-437,226
-45% -$22.6M 0.1% 209
2013
Q4
$46.6M Sell
976,422
-611,088
-38% -$27.9M 0.12% 217
2013
Q3
$72.1M Sell
1,587,510
-195,452
-11% -$8.92M 0.2% 137
2013
Q2
$79M Buy
+1,782,962
New +$79.6M 0.25% 118

Other funds holding MRK

Sculptor Capital's MRK Position: Q3 2022 in Review

Sculptor Capital sold out of Merck (MRK) in Q3 2022, closing a stake of 90,277 shares — an estimated $8.23M sold.

Sculptor Capital first reported a position in MRK in Q4 2013 and held it in 8 quarters. The position peaked at $58.4M in Q1 2019. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Sculptor Capital reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • Sculptor Capital sold 90,277 Merck shares in Q3 2022, an estimated $8.23M.
  • Sculptor Capital first reported a position in Merck in Q4 2013 and held it in 8 quarters.
  • Sculptor Capital's Merck position peaked at $58.4M in Q1 2019.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.